Four studies comparing treatment with sham stimulation
The researchers pooled studies involving people with restless legs syndrome. Their literature search covered several scientific databases through May 1, 2026. The comparator was sham stimulation, rather than simply no treatment.
The analysis focused in particular on syndrome severity, measured using the international IRLS-RS scale, and sleep quality, assessed using the Pittsburgh Sleep Quality Index, or PSQI. Only the PubMed abstract was consulted: it does not specify the total sample size, detailed participant characteristics or stimulation protocols.
A favorable signal, but not for every outcome
In the overall analysis pooling different follow-up time points, the authors report reduced symptoms and an improved sleep score compared with sham stimulation. These findings concern assessment scores: the abstract does not give the proportion of patients who achieved an improvement considered clinically meaningful.
The sleep findings are not consistent across the board, however. In the subgroup with primary restless legs syndrome, the analysis detects no statistically significant benefit on the PSQI. This does not demonstrate an absence of effect, but it prevents the overall finding from being extended to this subgroup without qualification.
The analyses also show no statistically significant improvement in anxiety or depression scores. The favorable signal for restless legs symptoms should therefore not be presented as a general psychological benefit.
What this review cannot establish
Four studies provide a limited evidence base. The abstract does not supply the information needed to examine their risk of bias, the heterogeneity of the results or the persistence of the effects. Nor does it allow a stimulation frequency or session schedule to be chosen.
Adverse effects, contraindications, funding and conflicts of interest are not documented in the excerpt provided. A favorable symptom outcome is therefore not enough to establish the benefit–risk balance. The authors themselves call for larger randomized trials to confirm their conclusions.
Limitations to keep in mind
Analysis based solely on a PubMed abstract, without consulting the full text. Total sample size, follow-up durations, methodological quality, tolerability, funding and conflicts of interest cannot be verified from the dossier.
What we can take away
Magnetic stimulation is a potential avenue for restless legs, not an option with established lasting effectiveness. Above all, this review supports the need for more robust trials.
Sources and provenance
- Repetitive transcranial magnetic stimulation for the treatment of restless legs syndrome: A meta-analysis.
Source date: 2026-10-16.
Journal Article, Meta-Analysis · Résumé PubMed uniquement, texte intégral non consulté


